Results 171 to 180 of about 2,747,893 (386)

Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus [PDF]

, 1999
Sally A. Litherland, Xiaolei Xie, Alan D. Hutson, Clive Wasserfall, Donna S. Whittaker, Jin‐Xiong She, Andrea Hofig, Melinda Dennis, Keely E. Fuller, Ralph W. Cook, Desmond Schatz, Lyle L. Moldawer, Michael Clare‐Salzler   +12 more
openalex   +1 more source

Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties [PDF]

, 2022
Valeria da Costa, Karina V. Mariño, Santiago A. Rodríguez-Zraquia, María Florencia Festari, Pablo Lores, Monique Costa, Mercedes Landeira, Gabriel A. Rabinovich, Sandra J. van Vliet, Teresa Freire   +9 more
openalex   +1 more source

Interplay between RNA‐protein interactions and RNA structures in gene regulation

FEBS Open Bio, EarlyView.
Methodological advances in mapping transcriptome‐wide RNA‐protein interactions and RNA structures have started to uncover the potential of RNP conformations in gene regulation. Competing RNA–RNA, RNA‐protein and protein–protein interactions shape the compaction and function of RNPs throughout their lifetime and may provide novel therapeutic targets in ...
Jenni Rapakko, Mauro Scaravilli, Minna‐Liisa Änkö   +2 more
wiley   +1 more source

Mature dendritic cells use endocytic receptors to capture and present antigens

, 2010
Craig D. Platt, K. Jessica, Cécile Chalouni, Melanie Ebersold, Hani Bou-Reslan, Richard A.D. Carano, Ira Mellman, Lélia Delamarre   +7 more
openalex   +1 more source

Distinct roles for transforming growth factor‐β₂ and tumour necrosis factor‐α in immune deviation elicited by hapten‐derivatized antigen‐presenting cells [PDF]

, 1999
HECKER‡, NIIZEKI§, Streilein
openalex   +1 more source

Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells

, 2022
Christian Lubich, Katharina Nora Steinitz, Brigitte Hoelbl, Thomas Prenninger, Pauline M. van Helden, Markus Weiller, Birgit M. Reipert   +6 more
openalex   +1 more source

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

FEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee, Jung Yoon Ho, In Sun Hwang, Youn Jin Choi   +3 more
wiley   +1 more source

Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism. [PDF]

Front Cell Infect Microbiol, 2023
Ju Y, Jin C, Chen S, Wang J, Li C, Wang X, Wang P, Yue L, Jiang X, Tuohetaerbaike B, Li Y, Sheng Y, Qimanguli W, Wang J, Chen F.   +14 more
europepmc   +1 more source

Overexpression of CDT1 inhibits cell cycle progression at S phase by interacting with the mini‐chromosome maintenance complex and causes DNA damage

FEBS Open Bio, EarlyView.
CDT1 is an essential protein for DNA replication licensing that loads the MCM complex, the eukaryotic replicative DNA helicase, onto replication origins. Overexpression of CDT1 induces cell cycle arrest at the S phase. Here we showed CDT1 inhibits the progression of replication forks by interacting with the MCM complex, leading to the stalling and ...
Takashi Tsuyama, Nonoka Takayama, Rina Tanaka, Yuuki Arai, Yohko Yamaguchi, Yuko Nawata, Yutaro Azuma, Shusuke Tada   +7 more
wiley   +1 more source

(Not) Home alone: Antigen presenting cell - T Cell communication in barrier tissues. [PDF]

Front Immunol, 2022
Neuwirth T, Knapp K, Stary G.
europepmc   +1 more source